LoPriore Vincent Sinsider trades

In SEC Form 4 filings, LoPriore Vincent S is listed as Executive Chairman of Hepion Pharmaceuticals, Inc. (HEPA). LoPriore Vincent S reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 14.

Companies and roles

Company	Role	Transactions	Last filed
HEPAHepion Pharmaceuticals, Inc.	Executive Chairman	2	Sep 14

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
HEPAHepion Pharmaceuticals, Inc.	Sep 3	Sep 14	P · derivative	12,500,000	$0.06	Purchase +$750,000	22,500,000	No	Form 4
HEPAHepion Pharmaceuticals, Inc.	Aug 19	Aug 21	A · derivative	1,345,500	$0.08	$107,640	1,345,500	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.